JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M010860200 on December 29, 2000

J. Biol. Chem., Vol. 276, Issue 18, 15107-15116, May 4, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/18/15107    most recent
M010860200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Farrant, R. D.
Right arrow Articles by Langley, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farrant, R. D.
Right arrow Articles by Langley, G. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Pyridoxal Phosphate De-activation by Pyrroline-5-carboxylic Acid
INCREASED RISK OF VITAMIN B6 DEFICIENCY AND SEIZURES IN HYPERPROLINEMIA TYPE II*

R. Duncan FarrantDagger §, Valerie Walker, Graham A. Mills||, John M. Mellor**, and G. John Langley**

From the Dagger  Physical Sciences, GlaxoWellcome Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, the  Department of Chemical Pathology, Southampton General Hospital, Tremona Road, Southampton, Hampshire SO16 6YD, the || School of Pharmacy and Biomedical Sciences, University of Portsmouth, White Swan Road, Portsmouth, Hampshire PO1 2DT, and the ** Department of Chemistry, University of Southampton, Highfield, Southampton, Hampshire SO17 1BJ, United Kingdom

We previously identified vitamin B6 deficiency in a child presenting with seizures whose primary diagnosis was the inherited disorder hyperprolinemia type II. This is an unrecognized association, which was not explained by diet or medication. We hypothesized that pyridoxal phosphate (vitamin B6 coenzyme) was de-activated by L-Delta 1-pyrroline-5-carboxylic acid, the major intermediate that accumulates endogenously in hyperprolinemia type II. The proposed interaction has now been investigated in vitro with high resolution 1H nuclear magnetic resonance spectroscopy and mass spectrometry at a pH of 7.4 and temperature of 310 K. Three novel adducts were identified. These were the result of a Claisen condensation (or Knoevenagel type of reaction) of the activated C-4 carbon of the pyrroline ring with the aldehyde carbon of pyridoxal phosphate. The structures of the adducts were confirmed by a combination of high performance liquid chromatography, nuclear magnetic resonance, and mass spectrometry. This interaction has not been reported before. From preliminary observations, pyrroline-5-carboxylic acid also condenses with other aromatic and aliphatic aldehydes and ketones, and this may be a previously unsuspected generic addition reaction. Pyrroline-5-carboxylic acid is thus found to be a unique endogenous vitamin antagonist. Vitamin B6 de-activation may contribute to seizures in hyperprolinemia type II, which are so far unexplained, but they may be preventable with long term vitamin B6 supplementation.


* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) .

§ To whom correspondence should be addressed: Analytical Technologies, GlaxoWellcome Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK. Tel.: 44-0-1438-768026; Fax: 44-0-1438-763352; E-mail: rdf17079@glaxowellcome.co.uk.


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Nutr.Home page
H. Mitsubuchi, K. Nakamura, S. Matsumoto, and F. Endo
Inborn Errors of Proline Metabolism
J. Nutr., October 1, 2008; 138(10): 2016S - 2020S.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. A. Marchitti, R. A. Deitrich, and V. Vasiliou
Neurotoxicity and Metabolism of the Catecholamine-Derived 3,4-Dihydroxyphenylacetaldehyde and 3,4-Dihydroxyphenylglycolaldehyde: The Role of Aldehyde Dehydrogenase
Pharmacol. Rev., June 1, 2007; 59(2): 125 - 150.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. C. Sleeman and C. J. Schofield
Carboxymethylproline Synthase (CarB), an Unusual Carbon-Carbon Bond-forming Enzyme of the Crotonase Superfamily Involved in Carbapenem Biosynthesis
J. Biol. Chem., February 20, 2004; 279(8): 6730 - 6736.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
O. Martin, M. C. Brandriss, G. Schneider, and A. T. Bakalinsky
Improved Anaerobic Use of Arginine by Saccharomyces cerevisiae
Appl. Envir. Microbiol., March 1, 2003; 69(3): 1623 - 1628.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.